These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 17262707)
21. Antiviral Effects of Clinically-Relevant Interferon-α and Ribavirin Regimens against Dengue Virus in the Hollow Fiber Infection Model (HFIM). Pires de Mello CP; Drusano GL; Rodriquez JL; Kaushik A; Brown AN Viruses; 2018 Jun; 10(6):. PubMed ID: 29890736 [TBL] [Abstract][Full Text] [Related]
22. Targeting heat shock factor 1 as an antiviral strategy against dengue virus replication in vitro and in vivo. Tsai TT; Chen CL; Tsai CC; Lin CF Antiviral Res; 2017 Sep; 145():44-53. PubMed ID: 28733114 [TBL] [Abstract][Full Text] [Related]
23. Lucidone suppresses dengue viral replication through the induction of heme oxygenase-1. Chen WC; Tseng CK; Lin CK; Wang SN; Wang WH; Hsu SH; Wu YH; Hung LC; Chen YH; Lee JC Virulence; 2018 Jan; 9(1):588-603. PubMed ID: 29338543 [TBL] [Abstract][Full Text] [Related]
24. Olive baboons: a non-human primate model for testing dengue virus type 2 replication. Valdés I; Gil L; Castro J; Odoyo D; Hitler R; Munene E; Romero Y; Ochola L; Cosme K; Kariuki T; Guillén G; Hermida L Int J Infect Dis; 2013 Dec; 17(12):e1176-81. PubMed ID: 24139794 [TBL] [Abstract][Full Text] [Related]
26. A nuclear transport inhibitor that modulates the unfolded protein response and provides in vivo protection against lethal dengue virus infection. Fraser JE; Watanabe S; Wang C; Chan WK; Maher B; Lopez-Denman A; Hick C; Wagstaff KM; Mackenzie JM; Sexton PM; Vasudevan SG; Jans DA J Infect Dis; 2014 Dec; 210(11):1780-91. PubMed ID: 24903662 [TBL] [Abstract][Full Text] [Related]
27. Prophylactic ribavirin treatment of dengue type 1 infection in rhesus monkeys. Malinoski FJ; Hasty SE; Ussery MA; Dalrymple JM Antiviral Res; 1990 Mar; 13(3):139-49. PubMed ID: 2353804 [TBL] [Abstract][Full Text] [Related]
29. Castanospermine vs. its 6-O-butanoyl analog: a comparison of toxicity and antiviral activity in vitro and in vivo. Ruprecht RM; Bernard LD; Bronson R; Gama Sosa MA; Mullaney S J Acquir Immune Defic Syndr (1988); 1991; 4(1):48-55. PubMed ID: 1984055 [TBL] [Abstract][Full Text] [Related]
30. Geraniin extracted from the rind of Nephelium lappaceum binds to dengue virus type-2 envelope protein and inhibits early stage of virus replication. Abdul Ahmad SA; Palanisamy UD; Tejo BA; Chew MF; Tham HW; Syed Hassan S Virol J; 2017 Nov; 14(1):229. PubMed ID: 29162124 [TBL] [Abstract][Full Text] [Related]
31. Antiviral effect of compounds derived from the seeds of Mammea americana and Tabernaemontana cymosa on Dengue and Chikungunya virus infections. Gómez-Calderón C; Mesa-Castro C; Robledo S; Gómez S; Bolivar-Avila S; Diaz-Castillo F; Martínez-Gutierrez M BMC Complement Altern Med; 2017 Jan; 17(1):57. PubMed ID: 28100218 [TBL] [Abstract][Full Text] [Related]
32. AR-12 suppresses dengue virus replication by down-regulation of PI3K/AKT and GRP78. Chen HH; Chen CC; Lin YS; Chang PC; Lu ZY; Lin CF; Chen CL; Chang CP Antiviral Res; 2017 Jun; 142():158-168. PubMed ID: 28238876 [TBL] [Abstract][Full Text] [Related]
33. Gefitinib and pyrrolidine dithiocarbamate decrease viral replication and cytokine production in dengue virus infected human monocyte cultures. Duran A; Valero N; Mosquera J; Fuenmayor E; Alvarez-Mon M Life Sci; 2017 Dec; 191():180-185. PubMed ID: 29055802 [TBL] [Abstract][Full Text] [Related]
34. Repurposing of prochlorperazine for use against dengue virus infection. Simanjuntak Y; Liang JJ; Lee YL; Lin YL J Infect Dis; 2015 Feb; 211(3):394-404. PubMed ID: 25028694 [TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial. Low JG; Sung C; Wijaya L; Wei Y; Rathore APS; Watanabe S; Tan BH; Toh L; Chua LT; Hou Y; Chow A; Howe S; Chan WK; Tan KH; Chung JS; Cherng BP; Lye DC; Tambayah PA; Ng LC; Connolly J; Hibberd ML; Leo YS; Cheung YB; Ooi EE; Vasudevan SG Lancet Infect Dis; 2014 Aug; 14(8):706-715. PubMed ID: 24877997 [TBL] [Abstract][Full Text] [Related]
37. Strategies for the treatment of dengue virus infections: a narrative account. De Clercq E Future Med Chem; 2010 Apr; 2(4):601-8. PubMed ID: 21426010 [TBL] [Abstract][Full Text] [Related]
39. Antiviral activity of lanatoside C against dengue virus infection. Cheung YY; Chen KC; Chen H; Seng EK; Chu JJ Antiviral Res; 2014 Nov; 111():93-9. PubMed ID: 25251726 [TBL] [Abstract][Full Text] [Related]
40. Important advances in the field of anti-dengue virus research. Julander JG; Perry ST; Shresta S Antivir Chem Chemother; 2011; 21(3):105-16. PubMed ID: 21233532 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]